Evidence map›Paper›PMID 38359079›Full record

ArticlePLoS pathogens2024

Enterovirus A71 does not meet the uncoating receptor SCARB2 at the cell surface.

Yorihiro Nishimura, Kei Sato, Yoshio Koyanagi, Takaji Wakita, Masamichi Muramatsu, Hiroyuki Shimizu, Jeffrey M Bergelson, Minetaro Arita

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Serial passagingFrontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yorihiro NishimuraDepartment of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.ORCID 0009-0007-7561-8509
Kei SatoLaboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto, Japan.
Yoshio KoyanagiLaboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto, Japan.
Takaji WakitaDepartment of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
Masamichi MuramatsuDepartment of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
Hiroyuki ShimizuDepartment of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
Jeffrey M BergelsonDivision of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Minetaro AritaDepartment of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
National Institute of Infectious Diseases · JPChildren's Hospital of Philadelphia · USKyoto University · JP

Funding

Cell Biology of Enterovirus Infection in Polarized Epithelial CellsR01AI072490 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BERGELSON, JEFFREY M. · 2008 to 2012
$1.9M
Pathogenic interaction of enterovirus 71 with PSGL-1 on human leukocytesR21AI111285 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BERGELSON, JEFFREY M. · 2014 to 2015
$449k
NIAID NIH HHS R01 AI072490NIAID NIH HHS R21 AI111285
6 · The paper itself

Abstract

Enterovirus A71 (EV-A71) infection involves a variety of receptors. Among them, two transmembrane protein receptors have been investigated in detail and shown to be critical for infection: P-selectin glycoprotein ligand-1 (PSGL-1) in lymphocytes (Jurkat cells), and scavenger receptor class B member 2 (SCARB2) in rhabdomyosarcoma (RD) cells. PSGL-1 and SCARB2 have been reported to be expressed on the surface of Jurkat and RD cells, respectively. In the work reported here, we investigated the roles of PSGL-1 and SCARB2 in the process of EV-A71 entry. We first examined the expression of SCARB2 in Jurkat cells, and detected it within the cytoplasm, but not on the cell surface. Further, using PSGL-1 and SCARB2 knockout cells, we found that although both PSGL-1 and SCARB2 are essential for virus infection of Jurkat cells, virus attachment to these cells requires only PSGL-1. These results led us to evaluate the cell surface expression and the roles of SCARB2 in other EV-A71-susceptible cell lines. Surprisingly, in contrast to the results of previous studies, we found that SCARB2 is absent from the surface of RD cells and other susceptible cell lines we examined, and that although SCARB2 is essential for infection of these cells, it is dispensable for virus attachment. These results indicate that a receptor other than SCARB2 is responsible for virus attachment to the cell and probably for internalization of virions, not only in Jurkat cells but also in RD cells and other EV-A71-susceptible cells. SCARB2 is highly concentrated in lysosomes and late endosomes, where it is likely to trigger acid-dependent uncoating of virions, the critical final step of the entry process. Our results suggest that the essential interactions between EV-A71 and SCARB2 occur, not at the cell surface, but within the cell.

Indexed as

EnterovirusEnterovirus A, HumanEnterovirus InfectionsCell LineCell MembraneHumansLysosomal Membrane ProteinsReceptors, ScavengerLysosomal Membrane ProteinsReceptors, ScavengerSCARB2 protein, human

Identifiers

PMID38359079
PMCPMC10901359
OpenAlexW4391839139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.